Riki Okita

The impact of inflammatory licensing on heme oxygenase-1–mediated induction of regulatory T cells by human mesenchymal stem cells

Dimitrios Mougiakakos, Regina Jitschin, C. Christian Johansson et al. · Blood · 2011 · 202 citations · Full text

Life Sciences, Cell Biology, Immunology +17

PD-L1 overexpression is partially regulated by EGFR/HER2 signaling and associated with poor prognosis in patients with non-small-cell lung cancer

Riki Okita, Ai Maeda, Katsuhiko Shimizu et al. · Cancer Immunology Immunotherapy · 2017 · 151 citations · Full text

Medicine, Cancer Biology, Oncology +10

Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer

Katsuhiko Shimizu, Riki Okita, Shinsuke Saisho et al. · World Journal of Surgical Oncology · 2015 · 107 citations · Full text

Medicine, Oncology, Surgery +15

CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer

Riki Okita, Toshiaki Saeki, Shigemitsu Takashima et al. · Oncology Reports · 2005 · 89 citations

Life Sciences, Immunology, Oncology +17

MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small cell lung cancer

Riki Okita, Takuro Yukawa, Yuji Nojima et al. · Cancer Immunology Immunotherapy · 2016 · 63 citations · Full text

Medicine, Immunology, Oncology +14